Leuko Labs
Madrid, Spain
Leuko Labs is developing PointCheck™, a noninvasive device designed to monitor white blood cell levels at home without requiring a blood draw. Utilizing light-based technology and artificial intelligence, the device images blood flow in superficial capillaries near the fingernail to assess immune system status. Targeted primarily at cancer patients and clinicians, it aims to enable earlier intervention for infection risks associated with low white blood cell counts. As an MIT spin-out backed by NIH funding and clinical trials, it represents a shift from lab-based testing to accessible home monitoring for oncology care.
Company Info
- Founded
- 2017
- Website
- leuko.io
Only accessible to MedStartr community members.
Join nowWhat do you think of Leuko Labs?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.